Freeze - Dried Human Serum Albumin M/P 65 Sensitive In Diagnostic Reagents

Quick Detail

Package & Delivery Lead Time

Detailed Description

Freeze - Dried Human Serum Albumin M/P 65 Sensitive In Diagnostic Reagents Quick detail # # Amino Acids Sequence:the same with pHSA # N-terminus:DAHKSEV # C-terminus:KLVAASQAALGL # Glycosylation:No # PI:4.8 # Thermal Stability:M/P 65 # Lipid Conjugation:the same with pHSA # Crystal Structure:the same with pHSA - - - - Test Item | Quality Standard | Appearance | Off-white to light beige lyophilized powder. | PH | 6.4-7.4 | Purity | more than 99% as determined by SDS-PAGE and HPLC analysis. | Residual DNA content | less than 0.5ng / g | Host cell protein | less than 0.5g / g | Sterility test | negative | Abnormal toxicity test | conforms | - - - - Description rHSA is derived from plant, that is animal free and any other protein impurity. Using the world leading purification technology, our rHSA has higer than 99% purity and stable batch consistency. rHSA has high precision and sensitivity in diagnostic reagent use. Advantages 1. Healthgen quality control systerm has been certified by ISO 9001:2008 and ensure standardized process as well as qualified products. 2.Healthgen recombinant human serum albumin is free of animal origin, which effectively avoid any potential risk of animal bacteria, prions, virus and contagious protein disease. 3. Recombinant human serum albumin (rHSA) has good efficacy, such as rHSA has the same second and tertiary structure, physiological and biochemical properties with HAS from plasma. In addition, compared with HSA from plasma, rHSA has a lower immune source stimulation, and plays a better role in accelerating cell growth and metabolism, because rHSA is animal component free, which can avoid the prions or virus contaminants. Supplemental Description Healthgen Biotech, always pay great attention to the original technological innovation and intellectual property protection, has the titles of Hubei Province Molecular Pharmaceutical Engineering Research Center and Protein Purification Research Center. The rice endosperm cell high expression technology platform and other core technology have applied and gained 13 domestic and international patents; and won the 2012 Hubei Provincial Science and technology invention Award, 2013 National Science and Technology Invention Award and China Patent Excellence Award. The project obtained the funding from the National Ministry of science and high technology 863 plan, Major national science and technology plan Major projects of new varieties of genetically modified organisms and Major projects for new drug discovery, the National Development and Reform Commission Pilot development of strategic emerging industries, National Ministry of science and technology innovation fund and state and local plans for all kinds of talented people funding. In July 2015, Healthgen Biotech became a public company on the "China New OTCBB", a national share transfer system for SMEs and officially known as the National Equities Exchange and Quotations, which is the first stock of the plant-derived pharmaceutical in China and even the world.

Basic Company Information

Wuhan Healthgen Biotechnology Co.,limited

Company Advantage

Detail Company Introduction